Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3882055/
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http/onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Long-term changes in the ghrelin-CB1R axis associated with the maintenance of lower body weight after sleeve gastrectomy (full – 2014) http/www.nature.com/nutd/journal/v4/n7/full/nutd201424a.html
A diet containing a nonfat dry milk matrix significantly alters systemic oxylipins and the endocannabinoid 2-arachidonoylglycerol (2-AG) in diet-induced obese mice. (full – 2014) http/www.nutritionandmetabolism.com/content/11/1/24
Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3895006/
The Endocannabinoid System - Back to the Scene of Cardiometabolic Risk Factors Control? (full – 2014) https/www.thieme-connect.com/products/ejournals/html/10.1055/s-0034-1375653
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects. (full – 2014) http/onlinelibrary.wiley.com/doi/10.1002/oby.20728/full
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full – 2014) http/www.hindawi.com/journals/bmri/2014/502542/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic NAcylethanolamines (full – 2014) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/22828945
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24631413
Endocannabinoids and energy homeostasis: An update. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24752980
Mitochondria: A Possible Nexus for the Regulation of Energy Homeostasis by the Endocannabinoid System? (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24801388
The endocannabinoid system and appetite: relevance for food reward. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24933167
GPR55: From orphan to metabolic regulator? (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24972076
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standardchow diets. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/25000488
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25138234
Genetic Sensitivity to the Bitter Taste of 6-n-Propylthiouracil (PROP) and Its Association with Physiological Mechanisms Controlling Body Mass Index (BMI) (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25166026
Endocannabinoid signaling and food addiction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25173635
Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25093427
Gut microbiota and obesity: Role in aetiology and potential therapeutic target (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25194177
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25352999
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25456065
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25542687
The role of gut hormones in appetite regulation (review) (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25532952
Cannabis use in relation to obesity and insulin resistance in the inuit population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25557382
The endocannabinoid system: directing eating behavior and macronutrient metabolism (full – 2015)http://journal.frontiersin.org/Journ...014.01506/full
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP secretion from enteroendocrine K-cells in response to fat ingestion (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25628425
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis (abst – 2015)http://www.ncbi.nlm.nih.gov/pubmed/25595882
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page – 2015)http://journals.lww.com/psychopharma...elated.14.aspx
Marijuana Could Be the Answer to Fighting These 3 Diseases (news – 2015) (may require free registration)http://www.fool.com/investing/genera...g-these-3.aspx
New study links marijuana use and low body weight among Nunavik Inuit (news – 2015)http://www.nunatsiaqonline.ca/storie...t_among_inuit/
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http/onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Long-term changes in the ghrelin-CB1R axis associated with the maintenance of lower body weight after sleeve gastrectomy (full – 2014) http/www.nature.com/nutd/journal/v4/n7/full/nutd201424a.html
A diet containing a nonfat dry milk matrix significantly alters systemic oxylipins and the endocannabinoid 2-arachidonoylglycerol (2-AG) in diet-induced obese mice. (full – 2014) http/www.nutritionandmetabolism.com/content/11/1/24
Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3895006/
The Endocannabinoid System - Back to the Scene of Cardiometabolic Risk Factors Control? (full – 2014) https/www.thieme-connect.com/products/ejournals/html/10.1055/s-0034-1375653
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects. (full – 2014) http/onlinelibrary.wiley.com/doi/10.1002/oby.20728/full
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full – 2014) http/www.hindawi.com/journals/bmri/2014/502542/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic NAcylethanolamines (full – 2014) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/22828945
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24631413
Endocannabinoids and energy homeostasis: An update. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24752980
Mitochondria: A Possible Nexus for the Regulation of Energy Homeostasis by the Endocannabinoid System? (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24801388
The endocannabinoid system and appetite: relevance for food reward. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24933167
GPR55: From orphan to metabolic regulator? (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24972076
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standardchow diets. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/25000488
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25138234
Genetic Sensitivity to the Bitter Taste of 6-n-Propylthiouracil (PROP) and Its Association with Physiological Mechanisms Controlling Body Mass Index (BMI) (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25166026
Endocannabinoid signaling and food addiction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25173635
Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25093427
Gut microbiota and obesity: Role in aetiology and potential therapeutic target (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25194177
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25352999
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25413674
Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25456065
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25542687
The role of gut hormones in appetite regulation (review) (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25532952
Cannabis use in relation to obesity and insulin resistance in the inuit population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25557382
The endocannabinoid system: directing eating behavior and macronutrient metabolism (full – 2015)http://journal.frontiersin.org/Journ...014.01506/full
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP secretion from enteroendocrine K-cells in response to fat ingestion (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25628425
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis (abst – 2015)http://www.ncbi.nlm.nih.gov/pubmed/25595882
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page – 2015)http://journals.lww.com/psychopharma...elated.14.aspx
Marijuana Could Be the Answer to Fighting These 3 Diseases (news – 2015) (may require free registration)http://www.fool.com/investing/genera...g-these-3.aspx
New study links marijuana use and low body weight among Nunavik Inuit (news – 2015)http://www.nunatsiaqonline.ca/storie...t_among_inuit/